Bay Island Cell
Shenzhen, China
◆ Total Raised
$19.6M
◆ Stage
series-a
◆ Location
Shenzhen, China
◆ Founded
2020
◆ Team size
1-10
◆ About Bay Island Cell
Cell therapy biotech company developing non-gene-editing universal CAR-T platform founded by former Legend Biotech executive Fan Xiaohu.
◆ What sets it apart
It claims a non-gene-edited universal CAR-T technology platform, which differentiates it from more common gene-edited allogeneic CAR-T approaches.
◆ Sectors
◆ Business
Modelbiotech
CustomerHospitals, clinicians, and patients needing CAR-T cancer therapies
◆ Notable
- Completed a RMB 140 million Series A financing round
- Presented early human data for diffuse large B-cell lymphoma
- Initiated an investigator-initiated clinical study for CD19 CAR-T
◆ Funding rounds
11 Jul 2026
Led by Shenzhen Capital Group, Songhe Capital
With CoStone Capital, Orient Fortune Capital
◆ Explore the market
◆ FAQ
What does Bay Island Cell do?
Cell therapy biotech company developing non-gene-editing universal CAR-T platform founded by former Legend Biotech executive Fan Xiaohu.
Where is Bay Island Cell based?
Bay Island Cell is based in Shenzhen, China, founded in 2020.
How much has Bay Island Cell raised?
Bay Island Cell has raised $19.6M in tracked funding and is currently at the series-a stage.
Who has invested in Bay Island Cell?
Investors in Bay Island Cell include Songhe Capital and Oriental Fortune Capital.